China, Oct. 9 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Real-world study of the effectiveness and tolerability of outpatient titration of OxyContin for the moderate and severe pain in cancer patients'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133896

Registration Time: 2026/10/09

Type: Observational study

Primary Sponsor: Cancer Hospital Chinese Academy of Medical Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345765

Published by HT Digital Content Services with permission from Health Daily Digest....